Vivia Biotech, S.L. - Product Pipeline Analysis, 2013 Update - New Market Research Report
Vivia Biotech S.L. (Vivia) is a biotechnology service provider. The company provides screening and profiling of drugs on patients blood samples. It offers ExviTec technology platform, which is used in hematologic cancer research. Vivia also provides treatments for hematological cancers such as leukemia, lymphoma and multiple myeloma. The company concentrates on personalized medicine test for hematologic cancers. Its technology platform consists of cytometry instruments. The company also has extended its research in Hematological Cancers to the area of Autoimmune Diseases....
View full press release